Objectives To determine whether intracerebroventricular injec tion of GalR1 agonist M617 would elevate GLUT4 expression in the cardiac muscle of type 2 diabetic *** The rats tested were divided into four groups:rats f...
Objectives To determine whether intracerebroventricular injec tion of GalR1 agonist M617 would elevate GLUT4 expression in the cardiac muscle of type 2 diabetic *** The rats tested were divided into four groups:rats from healthy and type 2 diabetic drug groupswere injected with 10 nM/kg/d M617 in5 μ *** muscle was processed for determi nation of GLUT4 mRNA expression and GLUT4 protein levels.
暂无评论